Growth Factor-Dependent and -Independent Activation of mTORC2

被引:48
作者
Knudsen, Jonas R. [1 ]
Fritzen, Andreas M. [1 ]
James, David E. [2 ,3 ,4 ]
Jensen, Thomas E. [1 ]
Kleinert, Maximilian [1 ,5 ,6 ]
Richter, Erik A. [1 ]
机构
[1] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Sect Mol Physiol, Copenhagen, Denmark
[2] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia
[3] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia
[4] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[5] Helmholtz Zentrum Muenchen, HDC, Inst Diabet & Obes, Neuherberg, Germany
[6] German Ctr Diabet Res DZD, Neuherberg, Germany
关键词
COMPLEX; 2; MTORC2; MAMMALIAN TARGET; GLUCOSE-UPTAKE; PHOSPHATIDIC-ACID; MEMBRANE LOCALIZATION; PROTEIN COMPLEXES; PHOSPHOINOSITIDE; 3-KINASE; MOTIF PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; AKT PHOSPHORYLATION;
D O I
10.1016/j.tem.2019.09.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The target of rapamycin complex 2 (TORC2) was discovered in 2002 in budding yeast. Its mammalian counterpart, mTORC2, was first described in 2004. Soon thereafter it was demonstrated that mTORC2 directly phosphorylates Akt on Ser473, ending a long search for the elusive 'second' insulin-responsive Akt kinase. In this review we discuss key evidence pertaining to the subcellular localization of mTORC2, highlighting a spatial heterogeneity that relates to mTORC2 activation. We summarize current models for how growth factors (GFs), such as insulin, trigger mTORC2 activation, and we provide a comprehensive discussion focusing on a new exciting frontier, the molecular mechanisms underpinning GF-independent activation of mTORC2.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 103 条
[1]
Mechanism of activation and function of protein kinase B [J].
Alessi, DR ;
Cohen, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62
[2]
Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B [J].
Anderson, KE ;
Coadwell, J ;
Stephens, LR ;
Hawkins, PT .
CURRENT BIOLOGY, 1998, 8 (12) :684-691
[3]
The Akt kinase:: Molecular determinants of oncogenicity [J].
Aoki, M ;
Batista, O ;
Bellacosa, A ;
Tsichlis, P ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14950-14955
[4]
Lysosomal mTORC2/PHLPP1/Akt Regulate Chaperone-Mediated Autophagy [J].
Arias, Esperanza ;
Koga, Hiroshi ;
Diaz, Antonio ;
Mocholi, Enric ;
Patel, Bindi ;
Cuervo, Ana Maria .
MOLECULAR CELL, 2015, 59 (02) :270-284
[5]
Generation and characterization of p38β (MAPK11) gene-targeted mice [J].
Beardmore, VA ;
Hinton, HJ ;
Eftychi, C ;
Apostolaki, M ;
Armaka, M ;
Darragh, J ;
McIlrath, J ;
Carr, JM ;
Armit, LJ ;
Clacher, C ;
Malone, L ;
Kollias, G ;
Arthur, JSC .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (23) :10454-10464
[6]
TORC2 Plasma Membrane Localization Is Essential for Cell Viability and Restricted to a Distinct Domain [J].
Berchtold, Doris ;
Walther, Tobias C. .
MOLECULAR BIOLOGY OF THE CELL, 2009, 20 (05) :1565-1575
[7]
mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology [J].
Betz, Charles ;
Stracka, Daniele ;
Prescianotto-Baschong, Cristina ;
Frieden, Maud ;
Demaurex, Nicolas ;
Hall, Michael N. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (31) :12526-12534
[8]
Rictor Phosphorylation on the Thr-1135 Site Does Not Require Mammalian Target of Rapamycin Complex 2 [J].
Boulbes, Delphine ;
Chen, Chien-Hung ;
Shaikenov, Tattym ;
Agarwal, Nitin K. ;
Peterson, Timothy R. ;
Addona, Terri A. ;
Keshishian, Hasmik ;
Carr, Steven A. ;
Magnuson, Mark A. ;
Sabatini, David M. ;
Sarbassov, Dos D. .
MOLECULAR CANCER RESEARCH, 2010, 8 (06) :896-906
[9]
Endoplasmic reticulum is a main localization site of mTORC2 [J].
Boulbes, Delphine R. ;
Shaiken, Tattym ;
Sarbassov, Dos D. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (01) :46-52
[10]
Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 [J].
Brunn, GJ ;
Williams, J ;
Sabers, C ;
Wiederrecht, G ;
Lawrence, JC ;
Abraham, RT .
EMBO JOURNAL, 1996, 15 (19) :5256-5267